Shared Decision Making for choosing renAl Replacement Therapy in chronic kidney disease patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006452

Enrollment

1194

Registered

2021-08-17

Start date

2021-03-19

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Active Comparator: Conventional group Behavioral: Education education as usual Experimental: Extensive Informed Decision Making group Behavioral: Education More informed and detailed edu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease grade 5 (defined as estimated glomerular filtration rate < 15 ml/dL/1.73m2 at least 2 times at intervals of 2 weeks or longer) Age between 19 and 80 years The nephrologists anticipate treating the patient with kidney replacement therapy within 12 months Written informed consent

Exclusion criteria

Exclusion criteria: Contraindication to perform peritoneal dialysis due to abdominal surgery Life expectancy is less than 6 months due to underlying diseases Patients who have enrolled in other clinical trials within 3 months or plan to participate in other clinical trials during this clinical trial period Patients judged by the investigator to be inappropriate for participation in this clinical trial.

Design outcomes

Secondary

Measure	Time frame
cost effectiveness analysis;compliance ;satisfaction;To compare the rate of unplanned dialysis among the groups	—

Primary

Measure	Time frame
hemodialysis vs. non hemodlalysis	—

Countries

Korea, Republic of

Contacts

Public ContactSejoong Kim

Seoul National University Bundang Hospital

sejoong@snubh.org+82-31-787-7051

Outcome results